美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco Dorsey Wright Healthcare Momentum ETF

58.76

+1.392.43%

盤後：58.800.0430+0.07%19:30 EDT

成交量：1.74萬

成交額：102.12萬

市值：2.84億

市盈率：19.22

高：59.14

開：57.66

低：57.66

收：57.37

52周最高：64.10

52周最低：44.47

股本：484.00萬

流通股本：484.00萬

量比：0.51

換手率：0.36%

股息：1.53

股息率：2.60%

每股收益(TTM):3.06

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

凱利泰子公司艾迪爾涉商業賄賂：被列為「特別嚴重失信」企業，集採衝擊、渠道失控兩頭擠壓

貝泰妮：注射用透明質酸鈉溶液獲得醫療器械註冊證

東方生物：獲得多項境外醫療器械註冊證

九強生物：取得I型膠原氨基端延長肽測定試劑盒醫療器械註冊證

麥科田赴港上市：併購拼出的醫療器械版圖，暗藏多重隱憂

港股異動 | 先健科技(01302)升逾3% LantvalTM主動脈瓣膜置換系統進入創新醫療器械特別審查程序

【券商聚焦】中信建投：醫療器械板塊業績有望逐步改善

深港攜手拓全球藥械市場，2026深圳國際高性能醫療器械展舉行

Revolution Medicines獲摩根士丹利首次覆蓋，給予「增持」評級，目標價255美元

透景生命(300642.SZ)控股子公司申報醫療器械註冊獲得受理

Stifel上調Revolution Medicines目標價至230美元

賽諾醫療：關於參加上海證券交易所科創板2026年半年度醫療器械及醫療設備行業集體業績説明會的公告

BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華

Roivant公司實驗性肺部疾病藥物在中期研究中達到預期目標

實驗性肺病藥物中期研究達主要終點 Roivant Sciences股價盤前飆升21.1%

Roivant公布Mosliciguat治療間質性肺病相關肺動脈高壓（Ph-Ild）的Phocus研究積極結果，並披露正在進行的Phrontier III期試驗

邁普醫學：可吸收止血流體明膠作為第三類醫療器械進入臨床試驗

中信建投：醫療器械業績持續改善醫療服務收入平穩增長

三諾生物：取得醫療器械註冊證及註冊變更文件

安圖生物：公司及子公司獲得四項醫療器械註冊證

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/PTH/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":58.757,"timestamp":1791576000000,"preClose":57.3658,"halted":0,"volume":17383,"hourTrading":{"tag":"盘后","latestPrice":58.8,"preClose":58.757,"latestTime":"19:30 EDT","volume":6,"amount":352.2346,"timestamp":1791588604239,"change":0.043,"changeRate":0.000732,"amplitude":0},"delay":0,"changeRate":0.024251383228334613,"floatShares":4840000,"shares":4840000,"eps":3.057033,"marketStatus":"休市中","change":1.3912,"latestTime":"10-09 16:00:00 EDT","open":57.66,"high":59.1447,"low":57.66,"amount":1021175.720865,"amplitude":0.025881,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":57.3658,"sharesOutstanding":2480000,"nav":57.33757,"aum":287288216.63,"dividendRate":0.02597,"bidAskSpread":0.001697,"preHourTrading":{"tag":"盘前","latestPrice":57.37,"preClose":57.3658,"latestTime":"07:00 EDT","volume":1,"amount":57.37,"timestamp":1791543606921,"change":0.0042,"changeRate":0.000073,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":58.8,"preClose":58.757,"latestTime":"19:30 EDT","volume":6,"amount":352.2346,"timestamp":1791588604239,"change":0.043,"changeRate":0.000732,"amplitude":0},"volumeRatio":0.5106189207267566,"impliedVol":0.2074,"impliedVolPercentile":0.9442},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4840000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5106189207267566,"shares":4840000,"dividePrice":1.5259,"high":59.1447,"amplitude":0.025881,"preClose":57.3658,"low":57.66,"week52Low":44.47,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":58.757,"eps":3.057033,"divideRate":0.02597,"volume":17383,"delay":0,"ttmEps":3.057033,"open":57.66,"prevYearClose":49.701,"prevWeekClose":60.2082,"prevMonthClose":60.76,"prevQuarterClose":60.76,"fiveDayClose":60.2082,"twentyDayClose":60.7692,"sixtyDayClose":58.2191},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666504386","title":"凱利泰子公司艾迪爾涉商業賄賂：被列為「特別嚴重失信」企業，集採衝擊、渠道失控兩頭擠壓","url":"https://stock-news.laohu8.com/highlight/detail?id=2666504386","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666504386?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 21:10","pubTimestamp":1789218656,"startTime":"0","endTime":"0","summary":"蓝鲸新闻向凯利泰方面求证具体涉案信息，截至发稿尚未收到回复。通过检索公开权威信息发现，除了此次事件，近年来，艾迪尔屡次被曝涉嫌商业贿赂。艾迪尔母公司凯利泰同样多次涉及商业贿赂事件。因为一旦被评定为“特别严重失信”，很可能会失去医保报销市场，对企业发展会带来巨大冲击。不过目前来看，作为名单中7家被评为“特别严重失信”的企业之一，艾迪尔尚未发表致歉声明。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789198644422913532","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["09996","BK1574","IEIH","LNGR","BK1100","AGNG","BK1583","LGHT","MDEV","MEDX","PTH","RSPH","300326","GDOC","BK0251","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525651","title":"貝泰妮：注射用透明質酸鈉溶液獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525651","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666525651?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 18:17","pubTimestamp":1789121838,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","MDEV","RSPH","LGHT","IEIH","HART","PTH","LNGR","GDOC","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666230575","title":"東方生物：獲得多項境外醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666230575","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666230575?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 18:05","pubTimestamp":1789121126,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","HART","LNGR","MDEV","RSPH","MEDX","GDOC","IEIH","AGNG","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544799","title":"九強生物：取得I型膠原氨基端延長肽測定試劑盒醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544799","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544799?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:50","pubTimestamp":1789113020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HART","LNGR","LGHT","AGNG","MDEV","IEIH","RSPH","MEDX","GDOC","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666938544","title":"麥科田赴港上市：併購拼出的醫療器械版圖，暗藏多重隱憂","url":"https://stock-news.laohu8.com/highlight/detail?id=2666938544","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666938544?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:35","pubTimestamp":1789112100,"startTime":"0","endTime":"0","summary":"近日，麦科田正式开启港股全球发售。盈利脆弱性在 2026 年一季度进一步暴露，上市前夕再度出现 252.7 万元亏损。靠并购快速拼出业务版图的麦科田，即将站上港股资本市场。对于麦科田而言，如何完成并购资产的深度整合、夯实自主研发实力、化解商誉与渠道危机，将决定它能否从并购拼凑的企业，蜕变为具备内生竞争力的医疗器械公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5385233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159883","BK1583","PTH","CALF","BK4585","RSPH","HART","KCE","LNGR","MYLD","BK1100","GDOC","09996","MEDX","BK4588","BK1574","IEIH","LGHT","02041","MDEV","AGNG","XMMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517543","title":"港股異動 | 先健科技(01302)升逾3% LantvalTM主動脈瓣膜置換系統進入創新醫療器械特別審查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517543","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517543?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:49","pubTimestamp":1789091380,"startTime":"0","endTime":"0","summary":"消息面上，先健科技发布公告，于2026年9月9日，本公司收到国家药品监督管理局的正式书面通知，确认由本公司附属公司深圳市健心医疗科技有限公司与国家心血管病中心中国医学科学院阜外医院联合研发的LantvalTM主动脉瓣膜置换系统进入国家药品监督管理局创新医疗器械特别审查程序。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01302","IEIH","PTH","VXUS","GDOC","BK1100","RSPH","159883","09996","KCAI","BK1583","HART","BK1600","MDEV","MEDX","BK4585","LGHT","BK4588","LNGR","BK1574","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666127155","title":"【券商聚焦】中信建投：醫療器械板塊業績有望逐步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2666127155","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666127155?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:18","pubTimestamp":1789089493,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。该机构认为，随着集采影响逐步出清叠加创新驱动和海外业务加速的双重助力，医疗器械板块业绩有望逐步改善。尽管季度业绩增速可能有所波动，Q3能否相比Q2加速尚不确定，但大趋势来看，26和27年年度业绩持续改善的确定性较强。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853","LNGR","LGHT","BK1600","01066","02252","PTH","BK1502","BK1587","GDOC","159883","IEIH","BK1610","BK1100","BK1583","601066","BK1593","BK1142","BK1161","BK1615","BK1591","BK1617","MEDX","LU0287142896.SGD","06826","MDEV","HK0000165453.HKD","AGNG","01302","BK1222","KCE","HART","02190","BK1589","00241","09996","RSPH","BK1247","BK1501","BK0276","LU0173614495.USD","BK1571","BK1585","BK1574","BK1515","BK1584","BK1189","02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666983512","title":"深港攜手拓全球藥械市場，2026深圳國際高性能醫療器械展舉行","url":"https://stock-news.laohu8.com/highlight/detail?id=2666983512","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666983512?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:10","pubTimestamp":1789089045,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1152091168.USD","SG9999003461.SGD","LU1008478684.HKD","MEDX","PTH","LU1152091754.HKD","BK1582","RSPH","GDOC","LU0067412154.USD","LNGR","159883","LU0880133367.SGD","LGHT","AGNG","BK1100","09996","BK1507","BK1185","00152","HART","BK1583","IEIH","MDEV","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186962882","title":"Revolution Medicines獲摩根士丹利首次覆蓋，給予「增持」評級，目標價255美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186962882","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186962882?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 18:10","pubTimestamp":1789035009,"startTime":"0","endTime":"0","summary":"摩根士丹利近日宣布首次覆盖生物制药公司Revolution Medicines, Inc.，并给予其“增持”评级。该机构将目标股价设定为每股255美元。这一举措标志着华尔街主要投行对这家专注于研发创新疗法的企业前景持乐观态度。值得注意的是，摩根士丹利的这一评级和价格目标，为投资者提供了新的参考坐标。此前，市场对Revolution Medicines的关注度持续攀升，尤其在肿瘤治疗领域，其管线布局备受瞩目。此次覆盖报告的出炉，或将在短期内影响该股的市场情绪与交易动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B2B36J28.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","PTH","RVMD","IE00BJJMRZ35.SGD","IDNA","IE00BJT1NW94.SGD","CANC","BBH","LU0109394709.USD","IE0009354923.USD","LU0889565916.HKD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666755282","title":"透景生命(300642.SZ)控股子公司申報醫療器械註冊獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2666755282","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666755282?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 11:50","pubTimestamp":1789012238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)发布公告，公司控股子公司上海脉示生物技术有限公司申报的医疗器械注册申请于近日获得了上海市药品监督管理局的受理，产品名称：四项抗癫痫药物浓度测定试剂盒(液相色谱串联质谱法)。该产品用于检测人体血清样本中的丙戊酸、奥卡西平代谢物(10,11-二氢-10-羟基卡马西平)、托吡酯、左乙拉西坦浓度。临床上用于丙戊酸、奥卡西平代谢物(10,11-二氢-10-羟基卡马西平)、托吡酯、左乙拉西坦血药浓度的监测。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LNGR","BK1583","MEDX","BK1574","300642","AGNG","BK0046","MDEV","PTH","159883","BK1100","IEIH","HART","BK0042","LGHT","RSPH","GDOC","BK0239","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554138","title":"Stifel上調Revolution Medicines目標價至230美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554138","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666554138?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 11:17","pubTimestamp":1789010271,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","IE00B2B36J28.USD","LU0889565916.HKD","UUP","BBH","LU0109394709.USD","UDN","CANC","PTH","IDNA","IE0009354923.USD","IE0009355771.USD","IE0002141913.USD","RVMD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582190","title":"賽諾醫療：關於參加上海證券交易所科創板2026年半年度醫療器械及醫療設備行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582190","media":"同花顺","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582190?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:39","pubTimestamp":1788950340,"startTime":"0","endTime":"0","summary":"    证券日报网讯9月9日，赛诺医疗发布公告称，公司计划于2026年9月17日15：00-17：00参加上海证券交易所组织的科创板2026年半年度医疗器械及医疗设备行业集体业绩说明 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260909/c679749361.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260909/c679749361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["MEDX","09996","AGNG","BK4585","LGHT","BK0251","159883","MDEV","XHE","GDOC","PTH","KSTR","HART","IHI","LNGR","BK4588","688108","IEIH","BK1574","BK1583","BK1100","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375206","title":"BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375206","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:58","pubTimestamp":1788875887,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-Sigma Lithium、Shake Shack、诺华工作区中用于查询单只股票行情的搜索字符串：STXBZ《今日展望》通讯：https://refini.tv/3LI4BU7《晨间新闻简报》：https://refini.tv/3dKUyB8路透9月8日-周二开盘时，华尔街主要股指涨跌不一，中东地区新一轮冲突推动油价升至7月下旬以来的最高水平，而市场正在等待本周晚些时候","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S45014M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","BK4597","LU0345769128.USD","IE00BLSP4452.SGD","BIB","IE00B66KJ199.SGD","BK4120","IE00B7SZL793.SGD","BK4534","LU1153585028.USD","LU0823416689.USD","LU2362541273.HKD","BK4550","RGTX","IONS","LU0122379950.USD","ZAP","LU1989772923.USD","LU1791710400.SGD","NVS","SG9999011175.SGD","XES","BK4581","LU0444973449.USD","LU0823417653.USD","LU1720051017.SGD","SG9999002232.USD","BK4567","PHVS","RGTZ","IBAT","LU0138981039.USD","LU2249611893.SGD","LU1066053197.SGD","BK4591","BBH","BK4578","BK4505","LU0251132253.USD","IBBQ","LU0266013472.USD","LU0353189680.USD","LU0868494617.USD","LU1718418525.SGD","BEX","IE00BJT1NW94.SGD","LU0225283273.USD","QTUP","ROIV","SIMS","LU0320765489.SGD","BK4121","BK4602","DYN","IE00BBT3K403.USD","LU0432979614.USD","VTWG","LU1983299246.USD","RGTI","IE00B19Z3581.USD","PBE","IE00B2B36J28.USD","IE0002141913.USD","IONX","LU2506951792.HKD","LU1642822529.SGD","LU1489326972.SGD","LU0823414551.USD","GNMX","BK4588","LU0070302665.USD","LU2265009873.SGD","LU0878866978.SGD","LU1989772840.SGD","LU2506951875.HKD","LU0187121727.USD","SGML","ILMN","GNOM","LU0320765992.SGD","LU0950375773.USD","TBXU","BK4007","SG9999013999.USD","BK4102","LU1894683264.USD","LU1815336760.USD","LU1989764664.SGD","LU0238689110.USD","LU0225771236.USD","BK4131","SGXZ57979304.SGD","BK4599","LU0068578508.USD","LU1861558580.USD","LU2112291526.USD","LU0823414478.USD","IE0009354923.USD","LU1894683348.USD","LU0889565916.HKD","LU1548497426.USD","LU0306806265.USD","BK4556","RGYY","LU2491050154.USD","LU0077335932.USD","LU1720051108.HKD","LU1791710582.SGD","LU1804176565.USD","WATS","IONC","BK4533","PFE","ICLN","LU0225284248.USD","LU0029874061.USD","LU1989771016.USD","CQTM","LU0267386448.USD","BK4141","LU2468319806.SGD","LU0985489474.SGD","AMGN","LU0114720955.EUR","RGTC","LU2506951958.HKD","LU2491050071.SGD","LU2089984988.USD","LU1064131342.USD","LU2506952170.USD","SG9999003800.SGD","LU2244417387.USD","LU0234572021.USD","LU0985481810.HKD","UNFI","BK4139","IE00BFTCPJ56.SGD","IE0034235188.USD","IONZ","BK4168","LU2098885051.SGD","LU2242646821.SGD","SHAK","BK4124","SMOG","BK4532","LU1057294990.SGD","BEG","IE00B4R5TH58.HKD","BK4170","IONQ","LU0321505439.SGD","LU1883839398.USD","LU2242652126.USD","LU2294711713.HKD","LU2362540622.SGD","LU2596442595.SGD","BHVN","LU2543165471.USD","LU1861559042.SGD","IE0002270589.USD","LU1988902786.USD","LU2357305700.SGD","PJP","SRPT","IE00BJJMRZ35.SGD","LU0306807586.USD","IOYY","LU2506952097.USD","IE0031619046.USD","IBB","LU0011850046.USD","LU0289739699.SGD","LU0128526141.USD","IE00B19Z3B42.SGD","LU0528227936.USD","BK4082","LU1093756325.SGD","LU1989764748.USD","LU2264538146.SGD","LU0433182093.SGD","SEI","SRPU","BE","VCLN","CTEC","LU0208291251.USD","LU0170899867.USD","LU1303367103.USD","CHRW","LU2362541513.USD","IE00B3T34201.USD","BK4541","LU1093756168.USD","LU0823417737.USD","LU0882574055.USD","USNG","LU0456855351.SGD","PPH","FRNW","IE000M9KFDE8.USD","LU1366192091.USD","IE00B19Z4B17.USD","BK4504","LU0444971666.USD","LU0211331839.USD","PTH","IONL","LU1066051498.USD","LU2357125470.USD","LU2087625088.SGD","BK4566","HYDR","LU0345769631.USD","SG9999002224.SGD","04332","LU0058720904.USD","BK4548","WQTM","BK4585","BK4209","LU0353189763.USD","LU1291159041.SGD","LU1061106388.HKD","LU2242649171.HKD","MEDX","LU2324357040.USD","NTLA","BSX","BK4568","OZEM","ALV","IE00BLSP4239.USD","SG9999001176.USD","LU0957808578.USD","BEC","ABM","LU0109394709.USD","LU1878469433.USD","LU2491049909.HKD","UPGR","LU0321505868.SGD","LU0476273544.USD","RGTU","EGGY","SG9999001440.SGD","BEZ","BK4179","LU0048584097.USD","LU1023059063.AUD","OIH","BK4535","SG9999001176.SGD","BK4182","LU1571399168.USD","CNRG","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665802322","title":"Roivant公司實驗性肺部疾病藥物在中期研究中達到預期目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665802322","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665802322?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865191,"startTime":"0","endTime":"0","summary":"Roivant公司实验性肺部疾病药物在中期研究中达到预期目标路透9月8日-Roivant公司周二表示，其试验性药物在针对一种肺部疾病相关高血压患者的中期研究中达到了主要目标，受此消息提振，该公司股价在盘前交易中上涨约20%。继上月获得美国批准用于治疗皮肤和肌肉疾病的药物Lisraya后，Roivant一直在扩充其后期研发管线。Roivant表示，该公司已启动一项后期临床试验，计划在全球范围内招募约375名患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4500RV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PTH","ROIV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192184963","title":"實驗性肺病藥物中期研究達主要終點 Roivant Sciences股價盤前飆升21.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192184963","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192184963?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:11","pubTimestamp":1788862270,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.股价在盘前交易中大涨21.1%，此前该公司宣布其研发的一款针对肺部疾病的实验性药物，在一项中期研究中成功达到了主要疗效终点。这一积极进展显著提振了市场信心，推动股价迅速走高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTH","ROIV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102884849","title":"Roivant公布Mosliciguat治療間質性肺病相關肺動脈高壓（Ph-Ild）的Phocus研究積極結果，並披露正在進行的Phrontier III期試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1102884849","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102884849?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:01","pubTimestamp":1788861671,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.今日宣布，其针对Mosliciguat在间质性肺病相关肺动脉高压患者中的Phocus研究取得了振奋人心的积极成果。与此同时，该公司还揭开了正在推进的Phrontier III期研究的面纱，这一举措标志着该候选药物在临床开发道路上又迈出了坚实一步。据悉，Phocus研究的数据不仅验证了药物的有效性，还为这一长期缺乏有效疗法的罕见病症带来了新的希望之光。值得注意的是，Phrontier III期研究的启动，无疑将进一步巩固Mosliciguat在该适应症领域的潜在治疗地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","PTH","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665332349","title":"邁普醫學：可吸收止血流體明膠作為第三類醫療器械進入臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332349","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665332349?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:14","pubTimestamp":1788855283,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","PTH","LGHT","AGNG","MDTX","IBBJ","RSPH","BMED","GDOC","IEIH","LNGR","IBBQ","MDEV","HART","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665434161","title":"中信建投：醫療器械業績持續改善 醫療服務收入平穩增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2665434161","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665434161?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 10:56","pubTimestamp":1788836160,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中信建投发布研报称，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。IVD：26Q2 IVD板块收入在过去两年来首次恢复正增长，利润端大幅增长。从收入端来看，二季度板块收入仍保持正增长，其中眼科医疗服务公司2025Q2低基数相对较低，但板块今年二季度收入增速相较一季度的增速有所降低，表明消费环境压力仍然存在。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1583","GDOC","HART","AGNG","PTH","LNGR","LGHT","MDEV","RSPH","BK0276","BK1100","159883","BK1574","IEIH","601066","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665231964","title":"三諾生物：取得醫療器械註冊證及註冊變更文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2665231964","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665231964?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:24","pubTimestamp":1788780275,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","GDOC","MEDX","IEIH","MDEV","HART","AGNG","PTH","LNGR","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315638","title":"安圖生物：公司及子公司獲得四項醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315638","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315638?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:03","pubTimestamp":1788775426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","MEDX","LNGR","MDEV","LGHT","HART","PTH","IEIH","AGNG","GDOC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}